Reporting of adverse drug reactions in randomised controlled trials – a systematic survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6904
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reporting of adverse drug reactions in randomised controlled trials – a systematic survey ; volume:1 ; number:1 ; day:12 ; month:9 ; year:2001 ; pages:1-6 ; date:12.2001
BMC clinical pharmacology ; 1, Heft 1 (12.9.2001), 1-6, 12.2001
- Urheber
-
Loke, Yoon Kong
- Beteiligte Personen und Organisationen
-
Derry, Sheena
SpringerLink (Online service)
- DOI
-
10.1186/1472-6904-1-3
- URN
-
urn:nbn:de:1111-2016072029676
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loke, Yoon Kong
- Derry, Sheena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
Comparing physicians’ and patients’ reporting on adverse reactions in randomized trials on acupuncture—a secondary data analysis
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Prospective reporting of statistical analysis plans for randomised controlled trials
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases
Adverse drug reactions
Assessment of the reporting quality of randomised controlled trials of massage
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
Inadequate reporting of sample size calculations in cluster randomised trials: a review
Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
Comparing physicians’ and patients’ reporting on adverse reactions in randomized trials on acupuncture—a secondary data analysis
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Prospective reporting of statistical analysis plans for randomised controlled trials
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases
Adverse drug reactions
Assessment of the reporting quality of randomised controlled trials of massage
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
Inadequate reporting of sample size calculations in cluster randomised trials: a review
Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
Comparing physicians’ and patients’ reporting on adverse reactions in randomized trials on acupuncture—a secondary data analysis
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Prospective reporting of statistical analysis plans for randomised controlled trials
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases
Adverse drug reactions
Assessment of the reporting quality of randomised controlled trials of massage
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal